your market intelligence analyst
Search Results
4,782 results
Your search is now limited to «Treatment» expert search. 06/04/2020 19:43
In response to the COVID-19 pandemic, clinicians may be finding new ways to continue their patients' treatment with buprenorphine, as providers relax requirements such as direct observation of treatment induction or urine drug screening," says Olfson.
More from
PharmacyChecker Blog 06/04/2020 18:04
Since the beginning of this century, billions of prescription opioid pills were wrongly, and in many cases unlawfully, pushed on and distributed to Americans.
More from PharmacyChecker Blog:
There, volunteers have stockpiled needle containers and naloxone, the overdose-reversing drug, donated by local organizations such as Southside Harm Reduction and Hope Network.
More from Minneapolis Star-Tribune (United States):
Kaiser Family Foundation 06/04/2020 16:42
Typically, a state would opt to do this when unmitigated access to a certain drug or class of drugs is especially critical such as with oncology drugs, epilepsy treatment, and antiretrovirals for HIV treatment and prevention.
More from Kaiser Family Foundation:
The Hill 06/04/2020 12:59
A former aide to President Obama lashed out at looters in New York, calling on them to not use the George Floyd protests as an excuse to ransack parts of the city.Speaking on the sidewalk Saturday night near a bus...
More from The Hill:
Seeking Alpha 06/04/2020 10:37
Given the ongoing opioid crisis, there is heightened interest in new classes of pain relievers.
More from Seeking Alpha:
Business Wire 06/04/2020 09:40
Through our acquisition of Prismic Pharmaceuticals in 2Q19, the Company is also making an effort to help address the opioid crisis by developing opioid-sparing prescription drugs utilizing the ultramicronized formulation of palmitoylethanolamide (PEA.
More from Business Wire:
HF10 therapy has demonstrated the ability to reduce or eliminate opioids in ≥65% of patients across six peer-reviewed clinical studies.
More from Healthcare Sales & Marketing Network:
PR Newswire 06/04/2020 07:00
The company's immediate priority is to address the opioid crisis by developing a non- hallucinogenic version of the psychedelic ibogaine.
More from PR Newswire:
LocalTechWire 06/04/2020 06:47
Propella Therapeutics, a development-stage venture focused on accelerated approvals of therapeutics with what it calls "mitigated risk," now calls Pittsboro home.
More from LocalTechWire: 06/04/2020 05:00
Using cannabis instead of opioids Published in The Journal of Pain, the review revealed that about 80 percent of 1,321 medical cannabis users reported using it in place of prescribed pain medications like opioids and benzodiazepines like Xanax and Valium ...
More from
Bio-Medicine.Org 06/04/2020 03:57
AUSTIN, Texas (PRWEB) June 04, 2020 When it comes to starting the average week, most of us simply try to power through Monday morning from start to end. Optimistically confronting our most challenging task first. When we’re done with our first undertaking, we quickly move on to the next and s...
More from Bio-Medicine.Org:
Insurance Journal 06/04/2020 01:00
I do see what the research is showing and there has been a lot less opioids prescribed for pain and a lot of other non-opioid pharmacological treatments.
More from Insurance Journal:
FirstPost (India) 06/04/2020 00:43
... ephedra harvesting in Afghanistan are still difficult to gauge, Mansfield suggested that in terms of scale and value “it is quite possible for the ephedra and meth industry to equal that of the opium and heroin economy.
More from FirstPost (India):
The Food and Drug Administration (FDA or Agency) is announcing the availability of additional draft and revised draft product-specific guidances. The guidances provide product-specific recommendations on, among other things, the design of bioequivalence (BE) studies to support abbreviated new drug applications (ANDAs). In the Federal Register of June 11, 2010, FDA announced the availability of a guidance for industry entitled ``Bioequivalence Recommendations for Specific Products'' that explained the process that would be used to make product-specific guidances available to the public on FDA's website. The guidances identified in this notice were developed using the process described in that guidance.
More from Federal Register (OFR):
If concomitant use is warranted, carefully observe the patient, particularly during treatment initiation and dose adjustment.
More from National Library of Medicine - DailyMed Drug Label Updates (NLM):

Therapeutic Areas

Clinical Trials and Phases

Business Issues

Companies - Public

Companies - Venture Funded

Financial Results

Global Markets

Global Risk Factors

Government Agencies

Job Titles

Legal and Regulatory

Cell Receptors


Diagnostics and Therapeutics


Drugs - Brand Names

Drugs - Generic



Health Care

Health and Wellness

Human Anatomy

Mechanisms of Action

Medical Devices



Strategic Scenarios



On this page, you see the results of the search you have run.  You may also view the following:

  •  Click on this drop-down menu on the right hand side of the page, to choose between the machine learning-produced Insights Reports, or the listing of concepts extracted from the results, in chart or list format. 

  •  View the number of search results returned for the search in each of your collections, and click on any of those numbers to view the entire listing of results from the chosen collection.

  •  Use the search adjustment drop-downs to change the scope, sorting, and presentation of your results.

  •  Show or hide the record’s caption (content description).

  •  Show actions that can be made with the search result record.

  •  Click on the Save button after running your search, to save it so that its results will be updated each time relevant new content is added to the designated collection. You may choose to be notified via search alerts.

Click here for more info on Search Results

Click here for more info on Machine Learning applications